about
Ventricular repolarization markers for predicting malignant arrhythmias in clinical practiceNovel treatment approaches in hypertensive type 2 diabetic patientsRenal denervation for treating resistant hypertension: current evidence and future insights from a global perspective.Negative effects of chlorthalidone on sympathetic nervous system and insulin resistance in hypertensive patients may be avoided with spironolactone: further studies are still needed.Aspirin for Primary Prevention of Cardiovascular Diseases: Current Concepts, Unanswered Questions and Future Directions.CHADS₂ score: its predictive capacity in clinical practice.Tp-e interval and Tp-e/QTc ratio: new choices for risk stratification of arrhythmic events in patients with hypertrophic cardiomyopathyLevels of uric acid and increased diastolic blood pressure: Risk factors for atrial fibrillation in patients older than 60 years.Atrial fibrillation and cryptogenic stroke. What is the current evidence? Role of electrocardiographic monitoring.Renal denervation with vincristine for the treatment of resistant hypertension: further investigations are needed to implement it globally[Renal sympathetic denervation in resistant hypertension]Natriuretic peptides, obesity and cardiovascular diseasesRecently approved and under investigation drugs for treating patients with heart failure[Role of renal inflammation in the physiopathology of salt-sensitive hypertension]Tpeak-Tend, Tpeak-Tend dispersion and Tpeak-Tend/QT in children and its relationship with clinical variables
P50
Q26798060-80B80225-9230-4A56-BC73-6095548AAC50Q34023579-8E0EB404-A8B1-4195-B72A-B474C1B04643Q37392940-BA7F1272-0656-48A4-9596-4C6809787093Q38581093-F289145B-B5D8-4721-8B63-1E398BE6DF76Q38930197-4CDD4600-4B1C-4761-8804-EADAEF40FB83Q42333842-8E6B4903-584D-4103-8E92-A5D0D5555DBAQ42336495-1AF5746E-00AE-48AC-AE10-42A47E46F4CBQ49611484-C9F62F84-7766-4D43-AF4E-3B27E7BB9045Q55038610-F4421AD7-A742-4934-AD44-5D0FDA16EEC4Q86076116-D846939E-08F2-47E4-B7DC-E922704E2085Q87132525-A81D73A6-D258-4F03-92B8-C8936CB2F12FQ87179595-E87F69E2-DAC4-4FE2-89A5-5B7EBD680ADDQ94463650-8010C3D6-5A48-48B1-B478-497E12EB5F95Q95434476-F0BB908F-155F-4052-8874-0A7D60AB2D6EQ96021744-DF4192B5-5115-4CCC-BA36-EC0E3E9B4913
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yaniel Castro Torres
@en
Yaniel Castro Torres
@nl
type
label
Yaniel Castro Torres
@en
Yaniel Castro Torres
@nl
prefLabel
Yaniel Castro Torres
@en
Yaniel Castro Torres
@nl
P31
P496
0000-0003-2019-284X